Intragel Therapeutics signs Urogen collaboration; up to $7M equity
URGN-linked Intragel Therapeutics and Urogen Pharma enter strategic collaboration and investment agreements, with Intragel securing up to $7M equity for a Phase 2 tumocure study.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.